Skip to main content
. Author manuscript; available in PMC: 2013 Apr 11.
Published in final edited form as: Circ Res. 2011 Aug 25;109(8):894–906. doi: 10.1161/CIRCRESAHA.111.251546

Figure 6. Inhibition of miR-132 attenuates SVP-induced activation of survival signaling.

Figure 6

A–E, Representative immunoblots and bar graphs showing the expression of pAkt (A), Bcl-2 (B), pGSK3-beta (C), pErk1/2 (D), and pFOXO1 (E) at 14 days post-MI in the myocardium of mice treated with naïve, scrambled-transfected or antimiR-132-transfected SVPs. Data are means±SE (n=5 mice per group). #P<0.05 and ##P<0.01 vs sham; *P<0.05 and **P<0.01 vs vehicle; δP<0.05 and δδP<0.01 vs nontransfected SVPs; ɸP<0.05 and ɸɸP<0.01 vs SCr-transfected SVPs.